Health Care: Drugs

Vertex Pharmaceuticals Inc (VRTX: NASDAQ)

$77.22 n/a | n/a%
12/08/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 1.03B 580.41M 1.21B 1.53B
Cost of Sales 62.17M 60.99M 81.91M 241.69M
Gross Operating Profit 970.17M 519.43M 1.13B 1.29B
Selling, General, and Administrative Expenses 376.57M 305.41M 356.19M 432.68M
Research & Development 995.92M 855.51M 882.10M 765.90M
Operating Income before D & A (EBITDA) -402.33M -641.49M -108.22M 86.76M
Depreciation & Amortization 62.34M 63.26M 48.37M 38.19M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -6.71M 30.40M 6.89M 309.00K
Special Income / Charges 0.00 0.00 -412.90M 0.00
Total Income Before Interest Expenses (EBIT) -473.59M -725.27M -603.12M 47.04M
Interest Expense 84.21M 72.86M 22.93M 15.04M
Pre-Tax Income -557.80M -798.13M -626.04M 32.00M
Income Taxes 30.38M 6.96M -122.42M -275.00K
Minority Interest -31.85M -4.19M -242.52M 55.90M
Net Income From Continuing Operations -588.18M -741.83M -503.62M 32.27M
Net Income From Discontinued Operations 0.00 -912.00K -183.93M -83.41M
Net Income From Total Operations -588.18M -742.75M -687.55M -51.13M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -556.33M -738.55M -445.03M -107.03M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-585.98M -690.91M -50.20M 34.12M
Preferred Dividends
Net Income Available To Common -588.18M -741.83M -503.62M 32.27M
Basic EPS from Continuing Ops. -2.31 -3.14 -2.24 0.15
Basic EPS from Discontinued Ops. 0.00 0.00 0.26 -0.65
Basic EPS from Total Operations -2.31 -3.14 -1.98 -0.50
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -2.31 -3.14 -1.98 -0.50
Basic Normalized Net Income/Share -2.30 -2.92 -0.22 0.16
EPS fr Continuing Ops. -2.31 -3.14 -2.24 0.15
EPS fr Discontinued Ops 0.00 0.00 0.26 -0.65
EPS fr Total Ops. -2.31 -3.14 -1.98 -0.50
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -2.31 -3.14 -1.98 -0.50
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-2.30 -2.92 -0.22 0.16
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with VRTX

Latest VRTX Headlines from TheStreet

More Financial News for VRTX

Press Releases for VRTX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter